<head></head><body><div class="content gradient-lighter">
  <div class="content-header">
    <div class="container">
      <button id="button-back"></button>
      <div class="title"><rich-text id="aca8ac2c-9d06-4ba5-a5a9-bd66c4a20f20">Treatment</rich-text></div>
    </div>
    <div class="subtitle"><rich-text id="df68b839-43fa-479c-939c-13b1d7b7da2d">Gaps &amp; Adherence</rich-text></div>
  </div>

  <div class="toggable-buttons-container tabbed">
    <button data-slide="0" data-toggable-button="" class="toggable-button "><rich-text id="18fd4866-44f3-4a64-b43d-ee9474f92c64">Adherence to treatment</rich-text></button>
    <button data-slide="1" data-toggable-button="" class="toggable-button "><rich-text id="b9e49169-5436-4dbd-a420-3099f00d5150">Gaps in treatment</rich-text></button>
  </div>

  <div class="tabbed-top">
    <div class="toggable-container text-container" data-slide="0">
      <h1><rich-text id="a48bbee0-f921-4ca9-89f8-38251f898887">Adherence to treatment of Bipolar Disorder</rich-text></h1>
      <div class="panel">
        <p class="quote"><rich-text id="b8174f78-726c-45c2-ad41-f801f4f7bd60">"Psychotropic non-adherence in those with BD contributes to a gap in medication efficacy and effectiveness."<sup></sup></rich-text></p>
        <p><rich-text id="c14362cb-85e8-4318-8ee8-a17e4bb3f031">Bipolar disorder is a cyclical disorder where the occurrence of mania or hypomania either alternate or occur with the depressive episodes<sup></sup>.</rich-text></p>

        <p><rich-text id="38046871-383f-40f3-9a3c-96e8c413fa8b">Approximately 20-60% rate of non-adherence to medication is estimated<sup></sup>.</rich-text></p>

        <p><rich-text id="4709e144-80e1-48f4-a460-eb55bd75bd33">40-50% of bipolar disorder patients are thought to not take medication regularly<sup></sup>.</rich-text></p>

        <p><rich-text id="1cf1ddf5-137d-4136-9908-77c5733f30ca">Up to 40% of patients with mania are either partially or completely nonadherent with their prescribed medications<sup></sup>.</rich-text></p>

        <p><rich-text id="f038b784-73f8-4593-b6ba-71da0f287865">Rate of 40.2% 'in the past week' and 42.8% 'in the past month' of non-adherence was self-reported in one study<sup></sup>.</rich-text></p>
      </div>

      <div class="panel">
        <h3><rich-text id="33a81152-7a56-4738-9a90-f0f94654a205">Associated with increased risk of:</rich-text></h3>
        <div class="flex space-x-2">
          <div class="flex-1 space-y-2">
            <ul class="list"><rich-text id="6a4a68f2-ad45-43ed-adeb-0e335492e28d"><li>Earlier onset<sup></sup>.</li><li>Greater need for health-care services<sup></sup>.</li><li>Increased hospital admissions<sup></sup>.</li><li>Mental health expenditures<sup></sup>.</li><li>Poor quality of life<sup></sup>.</li><li>Rapid cycling<sup></sup>.</li></rich-text></ul>
          </div>
          <div class="flex-1 space-y-2">
            <ul class="list"><rich-text id="d8ca74ca-f46c-4bb9-a368-c90b23876d48"><li>Comorbidity with anxiety, alcohol use disorder, obesity, obsessive compulsive disorder (OCD)<sup></sup></li><li>Relapse<sup></sup>.</li><li>Reoccurrence of acute manic episodes<sup></sup>.</li><li>Suicide<sup></sup>.</li></rich-text></ul>
          </div>
        </div>
      </div>

      <div class="panel">
        <h3><rich-text id="aee3e2fc-5e24-47c6-a32d-3de4b847efad">Reasons for non-adherence</rich-text><sup><rich-text id="8d24875a-06de-4ec5-af36-b064c61466f4">1</rich-text></sup><rich-text id="40dafaf4-d61b-401c-a12c-e41510b13829">:</rich-text></h3>
        <div class="flex space-x-2">
          <div class="flex-1 space-y-2">
            <h4><rich-text id="5ba69f10-fc59-407d-8ba4-486dc17fdd1c">Patient-level</rich-text></h4>
            <ul class="list"><rich-text id="2a494104-a717-4ad9-91a5-9ef612a1cbc3"><li>Younger age</li><li>Unmarried marital status</li><li>Negative attitude toward treatment</li><li>Stigma</li><li>Comorbidities</li><li>Severe psychotic symptoms</li><li>Cognitive deficits</li></rich-text></ul>
          </div>
          <div class="flex-1 space-y-2">
            <h4><rich-text id="79c15cee-adb2-4789-96fe-f73b1290adb5">External</rich-text></h4>
            <ul class="list"><rich-text id="bb5953e9-5f51-401d-a1b5-a625575d3c5d"><li>Medication type</li><li>Side-effects of medication</li><li>Poor relationship with clinician</li><li>Poor access to care</li></rich-text></ul>
          </div>
        </div>
      </div>

      <img src="./assets//MDD_Brain_Areas_ALT.jpg" class="shadow rounded-lg">

      <div class="panel">
        <h3><rich-text id="45382dd5-135d-485b-94d9-b283a7f2e075">Implications on the Bipolar brain:</rich-text></h3>
        <p><rich-text id="3030c198-7ffd-494a-b796-356b8173f9a5">Decreased left<span class="highlight-indigo text-white"></span>volume is observed in untreated patients compared to those treated with a mood stabilizer, lithium, and healthy participants<sup></sup>.</rich-text></p>

        <p><rich-text id="14ff8f66-16d2-4b27-85b6-7d5fc35510c6"><span class="highlight-yellow"></span>volumes have been shown to be smaller in patients who have had no or limited treatment with lithium compared to healthy participants<sup></sup>in fact, 14% larger hippocampal volume is reported in lithium-treated patients compared to untreated patients<sup></sup>.</rich-text></p>

        <p><rich-text id="ad01638a-ca1c-4243-bb6e-d4b4379b920d">Total grey matter volume has been shown to be increased in patients treated with lithium, compared to untreated patients and healthy participants<sup></sup>; over a 4 week period, grey matter volume was reported to be increased by 3% in Bipolar patients<sup></sup>.</rich-text></p>
      </div>

      <div class="references panel">
        <h4><rich-text id="dc918291-6280-41da-864c-262ee707ac80">References</rich-text></h4>
        <ol class="list"><rich-text id="03ccf39a-5709-4d17-9ad6-f731c385f409"><li>Levin JB, Krivenko A, Howland M<em></em>. Medication adherence in patients with Bipolar disorder: A comprehensive review. CNS Drugs. 2016;30:819-835.</li><li>PsychU Slide deck: Clinical and economic impact of bipolar disorder, June 2019; MRC2.PSY.D.00058. Accessed 14th August 2020.</li><li>Chakrabati S. Treatment-adherence in Bipolar disorder: A patient-centred approach. World J Psychiatry. 2016;6(4):339-409.</li><li>Sajatovik M, Ignacio RV, West JA<em></em>. Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic. Compr Psychiatry. 2009; 50:100-107.</li><li>Levin JB, Tatsuoka C, Cassidy KA<em></em>. Trajectories of medication attitudes and adherence behavior change in non-adherant bipolar patients. Compr Psychiatry. 2015;58:29-36.</li><li>Jawad I, Watson S, Haddad PM<em></em>. Medication nonadherence in bipolar disorder: a narrative review. Ther Adv Psychopharmacol. 2018;8(12):349–363.</li><li>Crowe M, Porter R, Inder M<em></em>. Effectiveness of interventions to improve medication adherence in bipolar disorder. Aust N J Psychiatry. 2012;46(4):317-326.</li><li>Sassi RB, Brambilla P, Hatch JP<em></em>. Reduced left anterior cingulate volumes in untreated Bipolar patients. Bio Psychiatry. 2004;56(7):467-475.</li><li>Hajek T, Cullis J, Novak T<em></em>. Hippocampal volumes in bipolar disorders: Opposing effects of illness burden and lithium treatment. Bipolar Disord. 2012;14(3):261-270.</li><li>Bearden CE, Thompson PM, Dutton RA<em></em>. Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology. 2008;33(6):1229-1238.</li><li>Sassi RB, Nicoletti M, Brambilla P<em></em>. Increased grey matter volime in lithium-treated bipolar disorder patients. Neurosci Lett. 2002;329(2):243-245.</li><li>Moore GJ, Bebchuk JM, Wilds IB<em></em>. Lithium-induced increase in human brain grey matter. Lancet. 2000;365:1241-1242.</li></rich-text></ol>
      </div>
    </div>

    <div class="toggable-container text-container" data-slide="1">
      <h1><rich-text id="e9fce8b7-d759-40eb-b1e6-245d39b60136">Gaps in treatment of Bipolar Disorder</rich-text></h1>
      <div class="panel">
        <p class="quote"><rich-text id="54956035-1f3b-44bf-9bea-6351a40657c5">"[Bipolar disorder] BD is often unrecognized or misdiagnosed. As a consequence, BD has a long untreated period."<sup></sup></rich-text></p>
        <p><rich-text id="57614160-4796-4f74-9e14-b416e146ae64">Bipolar disorder is episodic, where approximately 50% of patient’s first episode is depressive proving diagnosis difficult<sup></sup>.</rich-text></p>
        <p><rich-text id="0e2ba1d0-d223-4ed6-b031-c1fbd83fde92">Delay to first time treatment is associated with higher levels of depression, and higher number of episodes<sup></sup>.</rich-text></p>
        <p><rich-text id="ef81d89b-a08d-4774-8f52-cd18359af322">One study reported an average of 9.6 years of untreated Bipolar disorder in patients with Bipolar I and II, whilst a gap of 3 years was observed between the first mood episode and treatment<sup></sup>.</rich-text></p>
        <p><rich-text id="2115f8f4-7bae-4266-8846-6347c8ac189b">During the 2 years following treatment, 43.5% patients underwent first suicide attempt and 94% patients were hospitalized<sup></sup>.</rich-text></p>
        <p><rich-text id="18bd2872-628f-40f1-8249-ce1360dc75d5">It is estimated to take 5-10 years for treatment commencement from onset of illness to diagnosis<sup></sup>.</rich-text></p>
        <p><rich-text id="9b6dd667-0bdb-4bea-aeed-45b0f84f2f28">Delays in treatment is associated with increased risk of rapid cycling<sup></sup>and, excessive cannabis use<sup></sup>and suicide<sup></sup>.</rich-text></p>
      </div>

      <img src="./assets/MDD_Brain_Areas_ALT.jpg" class="shadow rounded-lg">

      <div class="panel">
        <h3><rich-text id="72000585-f193-4494-b13c-b6fafe5cd779">Implications on the Bipolar brain:</rich-text></h3>
        <p><rich-text id="e089c4eb-6f26-4337-a03d-d31486f90ae1">Decreased left<span class="highlight-indigo text-white"></span>volume is observed in untreated patients compared to those treated with a mood stabilizer, lithium, and healthy participants<sup></sup>.</rich-text></p>

        <p><rich-text id="3a2f3569-54fc-4789-92cd-ab15c888d848"><span class="highlight-yellow"></span>volumes have been shown to be smaller in patients who have had no treatment with lithium compared to healthy participants<sup></sup>.</rich-text></p>
      </div>

      <div class="references panel">
        <h4><rich-text id="0324af94-3b9a-4c5a-81c0-6da6edc0b1e8">References</rich-text></h4>
        <ol class="list"><rich-text id="619b8bae-c764-4896-95f1-e421a7e60fc4"><li>Zhang L, Yu X, Fang YR<em></em>. Duration of untreated bipolar disorder: A multicenter study. Sci Reports. 2017;7:44811.</li><li>Kvitland LR, Ringen PA, Aminoff SR<em></em>. Duration of untreated illness in first-treatment bipolar I disorder in relation to lcinical outcome and cannabis use. Psychiatry Res. 2016;246:762-768.</li><li>Post RM, Leverich GS, Kupka RW<em></em>. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood J Clin Psychiatry. 2010; 71(7):864-872.</li><li>Drancourt N, Etain B, Lajnef M<em></em>. Duration of untreated Bipolar disorder: Missed opportunities on the long road to optimal treatment. Acta Psychiatr Scand. 2013;127(2):136-144.</li><li>Wang X, Luo Q, Tian F<em></em>. Brain grey-matter volume alteration in adult patients with Bipolar disorder under different conditions: A voxel-based analysis. J Psychiatry Neurosci. 2019;44(2):89-101.</li><li>Altamura AC, Dell'Osso B, Duration of untreated illness and suicide in Bipolar disorder: A naturalistic study. Eur Arch Psychiatry Clin Neurosci. 2010;260(5):385-391.</li><li>Crowe M, Porter R, Inder M<em></em>. Effectiveness of interventions to improve medication adherence in bipolar disorder. Aust N J Psychiatry. 2012;46(4):317-326.</li><li>Sassi RB, Brambilla P, Hatch JP<em></em>. Reduced left anterior cingulate volumes in untreated Bipolar patients. Bio Psychiatry. 2004;56(7):467-475.</li></rich-text></ol>
      </div>
    </div>
  </div>
</div>
</body>